SOCS Proteins: Modulators of Neuroimmunoendocrine Functions: Impact on Corticotroph LIF Signaling
Christoph J. Auernhammer(LMU Klinikum), Шломо Мелмед(Cedars-Sinai Medical Center), Corinne Bousquet(Centre National de la Recherche Scientifique), Vera Chesnokova(Cedars-Sinai Medical Center)
Cited by 18
Related Papers
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Acromegaly
|Nature Reviews Disease Primers|2019|387